
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current SEPN market cap is 307.99M. The company's latest EPS is USD -1.6155 and P/E is -4.29.
Quarter End | Sep 2024 | Dec 2024 | |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 176k | 212k | |
Operating Income | -22.55M | -24.72M | |
Net Income | -20.52M | -20.67M |
Year End 31 December 2024 | 2022 | 2023 | 2024 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 151k | 1.08M |
Operating Income | -27.97M | -45.55M | -80.82M |
Net Income | -27.68M | 4.18M | -71.8M |
Quarter End | Sep 2024 | Dec 2024 | |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 174.28M | 456.55M | |
Total Liabilities | 37.53M | 36.51M | |
Total Equity | -87.41M | 420.05M |
Year End 31 December 2024 | 2022 | 2023 | 2024 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 36.12M | 130.87M | 456.55M |
Total Liabilities | 5.63M | 20.03M | 36.51M |
Total Equity | -44.2M | -38.37M | 420.05M |
Quarter End | Sep 2024 | Dec 2024 | |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Operating | -46.51M | -67.47M | |
Investing | -27.36M | -160.6M | |
Financing | 73.63M | 377.78M |
Year End 31 December 2024 | 2022 | 2023 | 2024 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Operating | -23.3M | -38.72M | -67.47M |
Investing | -1.29M | 22.12M | -160.6M |
Financing | 30.05M | 74.52M | 377.78M |
Market Cap | 307.99M |
Price to Earnings Ratio | -4.29 |
Price to Sales Ratio | 286.36 |
Price to Cash Ratio | 1.29 |
Price to Book Ratio | 0.73 |
Dividend Yield | - |
Shares Outstanding | 44.44M |
Average Volume (1 week) | 193.05k |
Average Volume (1 Month) | 203.45k |
52 Week Change | -70.51% |
52 Week High | 28.99 |
52 Week Low | 4.49 |
Spread (Intraday) | 1.17 (16.05%) |
Company Name | Septerna Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https:// |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions